Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 6
2005 2
2006 4
2007 8
2008 3
2009 7
2010 5
2011 9
2012 7
2013 8
2014 11
2015 13
2016 4
2017 1
2018 5
2019 7
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Results by year
Filters applied: . Clear all
Page 1
Tofacitinib versus methotrexate in rheumatoid arthritis.
Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV, Zang C, Zwillich SH, van Vollenhoven RF; ORAL Start Investigators. Lee EB, et al. N Engl J Med. 2014 Jun 19;370(25):2377-86. doi: 10.1056/NEJMoa1310476. N Engl J Med. 2014. PMID: 24941177 Free article. Clinical Trial.
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group. van der Heijde D, et al. Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22. Lancet. 2018. PMID: 30360964 Clinical Trial.
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Navarra SV, Guzmán RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, León MG, Tanasescu C, Nasonov E, Lan JL, Pineda L, Zhong ZJ, Freimuth W, Petri MA; BLISS-52 Study Group. Navarra SV, et al. Among authors: lan jl. Lancet. 2011 Feb 26;377(9767):721-31. doi: 10.1016/S0140-6736(10)61354-2. Epub 2011 Feb 4. Lancet. 2011. PMID: 21296403 Clinical Trial.
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.
van der Heijde D, Tanaka Y, Fleischmann R, Keystone E, Kremer J, Zerbini C, Cardiel MH, Cohen S, Nash P, Song YW, Tegzová D, Wyman BT, Gruben D, Benda B, Wallenstein G, Krishnaswami S, Zwillich SH, Bradley JD, Connell CA; ORAL Scan Investigators. van der Heijde D, et al. Arthritis Rheum. 2013 Mar;65(3):559-70. doi: 10.1002/art.37816. Arthritis Rheum. 2013. PMID: 23348607 Free article. Clinical Trial.
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study.
van der Heijde D, Strand V, Tanaka Y, Keystone E, Kremer J, Zerbini CAF, Cardiel MH, Cohen S, Nash P, Song YW, Tegzová D, Gruben D, Wallenstein G, Connell CA, Fleischmann R; ORAL Scan Investigators. van der Heijde D, et al. Arthritis Rheumatol. 2019 Jun;71(6):878-891. doi: 10.1002/art.40803. Epub 2019 Apr 24. Arthritis Rheumatol. 2019. PMID: 30666826 Free PMC article. Clinical Trial.
Glutathione peroxidase 8 negatively regulates caspase-4/11 to protect against colitis.
Hsu JL, Chou JW, Chen TF, Hsu JT, Su FY, Lan JL, Wu PC, Hu CM, Lee EY, Lee WH. Hsu JL, et al. Among authors: lan jl. EMBO Mol Med. 2020 Jan 9;12(1):e9386. doi: 10.15252/emmm.201809386. Epub 2019 Nov 29. EMBO Mol Med. 2020. PMID: 31782617 Free PMC article.
lncRNA NTT/PBOV1 Axis Promotes Monocyte Differentiation and Is Elevated in Rheumatoid Arthritis.
Yang CA, Li JP, Yen JC, Lai IL, Ho YC, Chen YC, Lan JL, Chang JG. Yang CA, et al. Among authors: lan jl. Int J Mol Sci. 2018 Sep 18;19(9):2806. doi: 10.3390/ijms19092806. Int J Mol Sci. 2018. PMID: 30231487 Free PMC article.
An Association of Gut Microbiota with Different Phenotypes in Chinese Patients with Rheumatoid Arthritis.
Chiang HI, Li JR, Liu CC, Liu PY, Chen HH, Chen YM, Lan JL, Chen DY. Chiang HI, et al. Among authors: lan jl. J Clin Med. 2019 Oct 24;8(11):1770. doi: 10.3390/jcm8111770. J Clin Med. 2019. PMID: 31652955 Free PMC article.
Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
Chen YM, Chen HH, Huang WN, Chen YH, Hsieh TY, Yang SS, Lan JL, Chen DY. Chen YM, et al. Among authors: lan jl. Int J Rheum Dis. 2019 Jun;22(6):1145-1151. doi: 10.1111/1756-185X.13582. Epub 2019 May 22. Int J Rheum Dis. 2019. PMID: 31117160
Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy.
Chen YM, Chang CY, Chen HH, Hsieh CW, Tang KT, Yang MC, Lan JL, Chen DY. Chen YM, et al. Among authors: lan jl. Arthritis Res Ther. 2018 Dec 5;20(1):268. doi: 10.1186/s13075-018-1763-0. Arthritis Res Ther. 2018. PMID: 30518408 Free PMC article.
99 results
Jump to page
Feedback